ASSESSMENT OF APOPTOSIS IN RELATION TO PROLIFERATION AND MUTATIONAL STATUS OF P53 GENE IN HEAD AND NECK CANCERS

Citation
Sd. Mundle et al., ASSESSMENT OF APOPTOSIS IN RELATION TO PROLIFERATION AND MUTATIONAL STATUS OF P53 GENE IN HEAD AND NECK CANCERS, International journal of oncology, 8(6), 1996, pp. 1257-1264
Citations number
27
Categorie Soggetti
Oncology
ISSN journal
10196439
Volume
8
Issue
6
Year of publication
1996
Pages
1257 - 1264
Database
ISI
SICI code
1019-6439(1996)8:6<1257:AOAIRT>2.0.ZU;2-F
Abstract
The present studies were undertaken to determine the incidence of apop tosis in plastic embedded head and neck (HN) tumor biopsies (n=31) usi ng in situ end labeling (ISEL) of fragmented DNA. The extent of sponta neous apoptosis in untreated tumors was correlated with histological g rade, percent S-phase cells (Labeling Index, LI) and with the mutation al status of p53 gene in these tumors. Additionally, the in vivo effec ts of chemo- and/or radiotherapy on apoptosis were evaluated in seven patients. In the majority of tumors studied (25/31) spontaneous apopto sis was virtually undetectable or was very low (1-15% positively label ed cells). Only 6 tumors showed intermediate to high apoptosis (>15% p ositively labeled cells). High apoptosis was more frequent in poorly d ifferentiated tumors (similar to 50%), as compared to well and moderat ely differentiated tumors. The median LI for 31 tumors studied was 20. 2%. The mean LI for moderately differentiated tumors (23.7+/-1.7%) was significantly higher than that in well differentiated (15.1+/-2.1%, p =0.005) and was comparable in poorly differentiated tumors (24.5%). Cy totoxic therapy significantly increased the degree of apoptosis in 5/7 specimens studied (p=0.03). Double labeling of 5 of these tumors befo re and after the therapy, combining ISEL with detection of IUdR/BrdU, showed compartmentalized apoptosis and proliferation with virtually no double labeled cells in any specimen. Interestingly, tumors with a mu tated p53 gene (n=6) showed intermediate to high degree of pretherapy, baseline apoptosis in contrast to low or undetectable levels of apopt osis in tumors bearing wild-type p53 (n=13, p=0.034). It appears that low levels of apoptosis and high proliferation may be characteristic o f HN tumors. The spontaneous apoptosis in HN tumors seems unrelated to mutations in the p53 gene. Moreover, our data also show that despite overall increase in apoptosis induced by cytotoxic therapy, some proli ferating tumor cells escaped the effects of therapy, which may contrib ute to the tumor relapse.